Chiara Martinelli received her Master Degree in Molecular Biology of the Cell at the University of Milan (Italy) in 2006.
In March 2011, she obtained her Ph.D. in Medical Nanotechnology from the European School of Molecular Medicine (SEMM) in Milan, under the supervision of Prof. Pier Giuseppe Pelicci. Her project focused on the selection of recombinant antibodies directed against the mutated form of nucleophosmin, a protein involved in the onset of human acute myeloid leukemia.
From 2012 to 2015 she was Post-Doc at FIRC Institute of Molecular Oncology (IFOM) in Milan. She participated to the development of gold/iron nanoparticles as contrast agents for cancer cell tracking.
From 2016 to 2018 she worked as a Post-Doctoral researcher at the University of Milan - Department of BioSciences, contributing to the identification of putative functional interactors of human RNaseH2 in tumor cells.
In June 2018, she joined the Smart Bio-Interfaces team at the Center for Micro-BioRobotics @SSSA in Pontedera (Pisa, Italy).